News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
682,253 Results
Type
Article (39256)
Company Profile (271)
Press Release (642726)
Section
Business (204117)
Career Advice (1979)
Deals (35428)
Drug Delivery (80)
Drug Development (81038)
Employer Resources (167)
FDA (16091)
Job Trends (14808)
News (344859)
Policy (32470)
Tag
Academia (2536)
Africa (712)
Alliances (49160)
Alzheimer's disease (1161)
Approvals (16019)
Arizona (178)
Artificial intelligence (86)
Asia (37078)
Australia (6045)
Bankruptcy (351)
Best Places to Work (11366)
Biosimilars (66)
Biotechnology (197)
Breast cancer (74)
C2C Services and Suppliers (78852)
California (2133)
Canada (1014)
Cancer (621)
Career advice (1649)
Cell therapy (153)
China (166)
Clinical research (63713)
Collaboration (196)
Colorado (87)
Compensation (112)
Connecticut (89)
COVID-19 (2508)
Cystic fibrosis (78)
Data (475)
Diabetes (99)
Diagnostics (6019)
Drug pricing (72)
Earnings (83810)
Employer resources (142)
Europe (79588)
Events (108462)
Executive appointments (185)
FDA (16396)
Florida (309)
Funding (189)
Gene therapy (105)
Georgia (68)
GLP-1 (527)
Government (4318)
Healthcare (18679)
Hotbed/Location (481549)
Illinois (274)
Indiana (155)
Infectious disease (2549)
Inflammatory bowel disease (96)
Interviews (306)
IPO (16255)
Job creations (3626)
Job search strategy (1413)
Kansas (94)
Layoffs (400)
Legal (7841)
Lung cancer (122)
Manufacturing (112)
Maryland (443)
Massachusetts (1747)
Medical device (13074)
Medtech (13079)
Mergers & acquisitions (19094)
Metabolic disorders (288)
Michigan (132)
Minnesota (226)
Neuroscience (1343)
New Jersey (654)
New York (668)
NextGen Class of 2024 (6512)
Non-profit (4463)
North Carolina (614)
Northern California (925)
Obesity (173)
Ohio (115)
Opinion (176)
Patents (80)
Pennsylvania (633)
People (56086)
Phase I (19743)
Phase II (28082)
Phase III (20939)
Pipeline (140)
Postmarket research (2555)
Preclinical (8385)
Radiopharmaceuticals (230)
Rare diseases (152)
Real estate (5895)
Regulatory (21340)
Research institute (2330)
Resumes & cover letters (347)
South America (1095)
Southern California (860)
Startups (3589)
Texas (276)
United States (9524)
Vaccines (494)
Washington State (269)
Weight loss (139)
Date
Last 7 days (654)
Last 30 days (2528)
Last 365 days (36670)
2024 (27592)
2023 (40175)
2022 (51318)
2021 (55889)
2020 (54240)
2019 (46659)
2018 (35103)
2017 (32201)
2016 (31596)
2015 (37655)
2014 (31392)
2013 (26432)
2012 (28648)
2011 (29348)
2010 (27413)
682,253 Results for "autoimmune inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases
Cullinan Therapeutics, Inc. today announced important updates about its plan to expand into autoimmune diseases, the scientific rationale for developing CLN-978 in autoimmune diseases, and initial clinical observations from its B cell non-Hodgkin lymphoma (B-NHL) study.
April 16, 2024
·
10 min read
Lone Star Bio
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - May 17, 2024
Forte Biosciences, Inc., a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, announced the issuance of equity inducement awards as required by the Nasdaq Stock Market Rules.
May 17, 2024
·
1 min read
Drug Development
BioMed X Start Collaboration in Autoimmunity Research with Servier
The new research team at the BioMed X Institute in Heidelberg will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.
June 26, 2024
·
3 min read
Business
Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced first quarter 2024 results and provided a business update.
May 13, 2024
·
6 min read
Drug Development
TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory Diseases
TRex Bio, Inc. (“TRexBio”) today announced that collaboration partner Eli Lilly and Company (“Lilly”) has initiated a Phase 1 first-in-human study of TRB-051, a modulator of immune effector cells, for treatment of autoimmune and inflammatory diseases.
June 26, 2024
·
3 min read
Biotech Bay
Kyverna Therapeutics and National Institutes of Health Co-Author Seminal Review on Cell Therapy for Autoimmunity in Nature Reviews Immunology
Kyverna Therapeutics, Inc. announced the publication in Nature Reviews Immunology of a manuscript co-authored with the National Institutes of Health titled “Chimeric antigen receptor T cell therapy for autoimmune disease”.
June 10, 2024
·
5 min read
Press Releases
IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
October 1, 2024
·
7 min read
Biotech Beach
GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity
GRI Bio, Inc. today announced that its abstracts have been accepted for presentation at the 14th International Congress on Autoimmunity being held May 17-20, 2024 in Ljubljana, Slovenia.
April 29, 2024
·
5 min read
Press Releases
Vera Therapeutics Announces Expanded Atacicept Development Program In Multiple Autoimmune Kidney Diseases
October 2, 2024
·
7 min read
Biotech Bay
EditCo Bio, Inc. Unveils Novel Knockout CD4+ T-cell Pools to Transform Cancer and Autoimmune Research
EditCo Bio, Inc., a pioneer at the forefront of genome engineering innovation, announced the launch of its Knockout CD4+ T-cell Pools.
April 18, 2024
·
3 min read
1 of 68,226
Next
